All of the SGLT2 inhibitors were associated with FG except ertugliflozin, which is likely explained by this drug only recently being approved for the treatment of diabetes
Why is the prescribed use so low
Theres no medical reason why having your gallbladder removed (cholecystectomy) should prevent you from using tirzepatide, and gallstone formation, a risk associated with GLP-1 weight-loss medications, is no longer relevant once the gallbladder has been removed
FAQ Q Is Mounjaro dangerous
Objective This review aims to comprehensively summarize the role of GLP-1 RAs in the management of diabetes mellitus (DM) and cardiovascular disease (CVD), with a particular emphasis on the underlying signal transduction pathways and their therapeutic potential
Clinical Diabetes : A Publication of the American Diabetes Association, 38 (1), 109-111